Alyssa Brooke Morgan, | |
96 Lock Ave, Nitro, WV 25143-1280 | |
(304) 955-8283 | |
Not Available |
Full Name | Alyssa Brooke Morgan |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 96 Lock Ave, Nitro, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114599867 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alyssa Brooke Morgan, 96 Lock Ave, Nitro, WV 25143-1280 Ph: (304) 955-8283 | Alyssa Brooke Morgan, 96 Lock Ave, Nitro, WV 25143-1280 Ph: (304) 955-8283 |
News Archive
SeraCare Life Sciences, Inc. today announced that the Company has developed a new series of controls in its ACCURUN portfolio to monitor and validate molecular diagnostic test performance for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG). Through collaboration with instrument and reagent manufacturers, SeraCare has optimized the ACCURUN 341 Nucleic Acid Positive controls specifically for use with the three most popular assays currently on the market; the Gen-Probe APTIMA Combo 2 Assay, the Roche COBAS AMPLICOR CT/NG Test, and the Becton, Dickinson BD ProbeTec ET System.
A major research effort to develop medical products to diagnose, prevent and treat the short- and long-term consequences of radiation exposure after a radiological or nuclear terrorist attack has been renewed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.
NYU Langone Medical Center is pleased to announce that it has established The Smilow Comprehensive Prostate Cancer Center with a $5 million gift from Joel E. Smilow, a member of the Board of Trustees at NYU Langone Medical Center and New York University. The Smilow Center is dedicated to providing comprehensive, state-of-the-art personalized care for men with prostate cancer as well as educating men and their families about the disease and the wide range of treatment options available today.
The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. The patches will be studied to evaluate their potential role as part of the worldwide efforts to eradicate polio.
› Verified 9 days ago
Mrs. Tara D. Slater, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 Blake Rd, Nitro, WV 25143 Phone: 304-755-2418 |